First-Episode Psychosis
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Innovation PharmaceuticalsMA - Wakefield
1 program1
Financial Incentive and Text-MessagesPhase 11 trial
Active Trials
Vera TherapeuticsBRISBANE, CA
1 programSpecialized Early Engagement Support ServiceN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Innovation PharmaceuticalsFinancial Incentive and Text-Messages
Vera TherapeuticsSpecialized Early Engagement Support Service
Clinical Trials (2)
Total enrollment: 145 patients across 2 trials
Trial to Increase FEP Attendance
Start: Feb 2025Est. completion: Mar 2026145 patients
Phase 1Active Not Recruiting
Clinical Interviews With Detainees With Early Psychosis
Start: Jan 2020Est. completion: Mar 2023
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.